# Adalimumab in Adult Japanese Subjects With Psoriasis

> **NCT00647400** · PHASE2,PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 147 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **BIOLOGICAL:** adalimumab
- **BIOLOGICAL:** adalimumab

## Key facts

- **NCT ID:** NCT00647400
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-09
- **Final completion:** 2010-04
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2011-04-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647400, "Adalimumab in Adult Japanese Subjects With Psoriasis". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00647400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*